Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Bossi P. Baggi A, et al. Among authors: saponara m. Eur J Cancer. 2021 Nov;157:250-258. doi: 10.1016/j.ejca.2021.08.018. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536948
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers.
Saponara M, Pala L, Conforti F, Rubatto M, De Risi I, Spagnolo F, Guida M, Bossi P, Quaglino P, Queirolo P. Saponara M, et al. Ther Adv Med Oncol. 2020 Nov 20;12:1758835920977002. doi: 10.1177/1758835920977002. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33273966 Free PMC article.
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258].
Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Zamparini M, Bossi P. Baggi A, et al. Among authors: saponara m. Eur J Cancer. 2022 May;166:309-310. doi: 10.1016/j.ejca.2022.02.027. Epub 2022 Mar 24. Eur J Cancer. 2022. PMID: 35341663 Free article. No abstract available.
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
Pala L, Conforti F, Saponara M, De Pas T, Giugliano F, Omodeo Salè E, Jemos C, Rubatto M, Agostini A, Quaglino P, Fava P, Fierro MT, Queirolo P. Pala L, et al. Among authors: saponara m. Semin Oncol. 2020 Oct;47(5):302-304. doi: 10.1053/j.seminoncol.2020.07.010. Epub 2020 Aug 7. Semin Oncol. 2020. PMID: 32883537 Free PMC article.
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.
Pinato DJ, Ferrante D, Aguilar-Company J, Bower M, Salazar R, Mirallas O, Sureda A, Bertuzzi A, Brunet J, Lambertini M, Maluquer C, Pedrazzoli P, Biello F, Lee AJX, Sng CCT, Liñan R, Rossi S, Carmona-García MC, Sharkey R, Eremiev S, Rizzo G, Bain HD, Yu T, Cruz CA, Perachino M, Saoudi-Gonzalez N, Fort-Culillas R, Doonga K, Fox L, Roldán E, Zoratto F, Gaidano G, Ruiz-Camps I, Bruna R, Patriarca A, Shawe-Taylor M, Fusco V, Martinez-Vila C, Berardi R, Filetti M, Mazzoni F, Santoro A, Delfanti S, Parisi A, Queirolo P, Aujayeb A, Rimassa L, Prat A, Tabernero J, Gennari A, Cortellini A; OnCovid study group. Pinato DJ, et al. Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036. Epub 2022 May 23. Eur J Cancer. 2022. PMID: 35704976 Free PMC article.
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry.
Cortellini A, Salazar R, Gennari A, Aguilar-Company J, Bower M, Bertuzzi A, Brunet J, Lambertini M, Maluquer C, Pedrazzoli P, Lee AJ, Carmona-García M, Newsom-Davis T, Van Hemelrijck M, Plaja A, Zambelli A, Tondini C, Generali D, Bertulli R, Diamantis N, Mukherjee U, Rizzo G, Yu T, Zoratto F, Bruna R, Sureda A, Martinez-Vila C, Cantini L, Mazzoni F, Grosso F, Parisi A, Saponara M, Prat A, Pinato DJ; On Covid study group. Cortellini A, et al. Among authors: saponara m. Eur J Cancer. 2022 Jul;170:10-16. doi: 10.1016/j.ejca.2022.03.019. Epub 2022 Apr 26. Eur J Cancer. 2022. PMID: 35576848 Free PMC article.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Pinato DJ, Tabernero J, Bower M, Scotti L, Patel M, Colomba E, Dolly S, Loizidou A, Chester J, Mukherjee U, Zambelli A, Dalla Pria A, Aguilar-Company J, Ottaviani D, Chowdhury A, Merry E, Salazar R, Bertuzzi A, Brunet J, Lambertini M, Tagliamento M, Pous A, Sita-Lumsden A, Srikandarajah K, Colomba J, Pommeret F, Seguí E, Generali D, Grisanti S, Pedrazzoli P, Rizzo G, Libertini M, Moss C, Evans JS, Russell B, Harbeck N, Vincenzi B, Biello F, Bertulli R, Liñan R, Rossi S, Carmona-García MC, Tondini C, Fox L, Baggi A, Fotia V, Parisi A, Porzio G, Saponara M, Cruz CA, García-Illescas D, Felip E, Roqué Lloveras A, Sharkey R, Roldán E, Reyes R, Earnshaw I, Ferrante D, Marco-Hernández J, Ruiz-Camps I, Gaidano G, Patriarca A, Bruna R, Sureda A, Martinez-Vila C, Sanchez de Torre A, Cantini L, Filetti M, Rimassa L, Chiudinelli L, Franchi M, Krengli M, Santoro A, Prat A, Van Hemelrijck M, Diamantis N, Newsom-Davis T, Gennari A, Cortellini A; OnCovid study group. Pinato DJ, et al. Among authors: saponara m. Lancet Oncol. 2021 Dec;22(12):1669-1680. doi: 10.1016/S1470-2045(21)00573-8. Epub 2021 Nov 3. Lancet Oncol. 2021. PMID: 34741822 Free PMC article. Clinical Trial.
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Pinato DJ, Aguilar-Company J, Ferrante D, Hanbury G, Bower M, Salazar R, Mirallas O, Sureda A, Plaja A, Cucurull M, Mesia R, Townsend S, Jackson A, Dalla Pria A, Newsom-Davis T, Handford J, Sita-Lumsden A, Apthorp E, Vincenzi B, Bertuzzi A, Brunet J, Lambertini M, Maluquer C, Pedrazzoli P, Biello F, Sinclair A, Bawany S, Khalique S, Rossi S, Rogers L, Murphy C, Belessiotis K, Carmona-García MC, Sharkey R, García-Illescas D, Rizzo G, Perachino M, Saoudi-Gonzalez N, Doonga K, Fox L, Roldán E, Gaidano G, Ruiz-Camps I, Bruna R, Patriarca A, Martinez-Vila C, Cantini L, Zambelli A, Giusti R, Mazzoni F, Caliman E, Santoro A, Grosso F, Parisi A, Queirolo P, Aujayeb A, Rimassa L, Prat A, Tucci M, Libertini M, Grisanti S, Mukherjee U, Diamantis N, Fusco V, Generali D, Provenzano S, Gennari A, Tabernero J, Cortellini A; OnCovid study group. Pinato DJ, et al. Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2. Lancet Oncol. 2022. PMID: 35660139 Free PMC article.
Different Response to Immunotherapy According to Melanoma Histologic Subtype.
Pala L, Conforti F, Pagan E, Bagnardi V, De Pas TM, Mazzarol G, Barberis M, Pennacchioli E, Orsolini G, Prestianni P, Zagami P, Nicolo' E, Patanè D, Saponara M, Queirolo P. Pala L, et al. Among authors: saponara m. J Immunother. 2022 Feb-Mar 01;45(2):119-124. doi: 10.1097/CJI.0000000000000403. J Immunother. 2022. PMID: 34908006
112 results